Related Experiment Videos

Adenosine 3'5'-cyclic monophosphate dependent protein kinase in human adrenocortical tumors

Insights

Adrenocortical tumors show altered protein kinase activity, impacting response to ACTH. Defects in ACTH receptors or cAMP-dependent protein kinases can cause tumor dysfunction.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Oncology

Background:

  • Adrenocortical tumors can exhibit resistance to adrenocorticotropic hormone (ACTH).
  • Protein kinases play a crucial role in cellular signaling pathways, including steroidogenesis.

Purpose of the Study:

  • To investigate protein kinase activity in human adrenocortical tumors.
  • To compare kinase activity with normal adrenal tissue and correlate it with ACTH responsiveness.

Main Methods:

  • Analysis of protein kinase activity in four human adrenocortical tumors and normal adrenal tissue.
  • Assessment of ACTH receptor function and steroidogenesis response.
  • DEAE-cellulose chromatography to resolve protein kinase isoenzymes.

Main Results:

  • Two tumors with ACTH receptor anomalies had normal protein kinase activity.
  • Two tumors with normal ACTH receptors showed altered protein kinase activity (either higher or lower basal and cAMP-stimulated levels).
  • One tumor exhibited a loss of a specific cAMP-dependent protein kinase isoenzyme (II) and altered activation of another (I).

Conclusions:

  • Lack of ACTH response in adrenocortical tumors can stem from ACTH receptor defects.
  • Dysfunctional cAMP-dependent protein kinases are also implicated in adrenocortical tumor non-responsiveness to ACTH.

Related Concept Videos